Concepedia

Christine L. Hann

CL

Statistics

Publications

83

Citations

13.5K

H-Index

48

Active since

1990

Affiliations

Johns Hopkins University(Current)

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins Medicine

Memorial Sloan Kettering Cancer Center

Bloomberg (United States)

Christine L. Hann is an author at Johns Hopkins University specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1990–2025

83

Publications

83

Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

Daniel D. Von Hoff, Patricia LoRusso, Charles M. Rudin et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

, , +17

Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449

Charles M. Rudin, Christine L. Hann, John Laterra et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

, , +17

<i>Smoothened</i> Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma

Robert L. Yauch, Gerrit J.P. Dijkgraaf, Bruno Alicke et al. · Science · 2009 · 844 citations · Full text

, , +17

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

Leena Gandhi, D. Ross Camidge, Moacyr Oliveira et al. · Journal of Clinical Oncology · 2011 · 591 citations · Full text

, , +17

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

Charles M. Rudin, Christine L. Hann, Edward B. Garon et al. · Clinical Cancer Research · 2012 · 551 citations · Full text

, , +17

1–5 of 83